sj-pdf-1-cep-10.1177_03331024211007789 - Supplemental material for Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach

Autor:	Cohen-Barak, Orit, Radivojevic, Andrijana, Jones, Aksana, Fiedler-Kelly, Jill, Gillespie, Michael, Brennan, Michael, Gutman, Dikla, Rasamoelisolo, Michele, Hallak, Hussein, Loupe, Pippa, Kessler, Yoel, Xiaoping Ning, Levi, Micha, Ahn, Andrew H, Rabinovich-Guilatt, Laura
Rok vydání:	2021
Předmět:	FOS: Psychology FOS: Clinical medicine 170199 Psychology not elsewhere classified 110319 Psychiatry (incl. Psychotherapy) 110306 Endocrinology 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 110904 Neurology and Neuromuscular Diseases Neuroscience
ISSN:	0333-1024
DOI:	10.25384/sage.14617919
Popis:	Supplemental material, sj-pdf-1-cep-10.1177_03331024211007789 for Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach by Orit Cohen-Barak, Andrijana Radivojevic, Aksana Jones, Jill Fiedler-Kelly, Michael Gillespie, Michael Brennan, Dikla Gutman, Michele Rasamoelisolo, Hussein Hallak, Pippa Loupe, Yoel Kessler, Xiaoping Ning, Micha Levi, Andrew H Ahn and Laura Rabinovich-Guilatt in Cephalalgia
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82f4c2e364d60a8bca2925e334b1cde Zobrazit plný text záznamu